5 October 2024

Howe Street Reporter Title

Tag: bright minds biosciences

  • The top 10 most cashed up psychedelics companies right now

    The top 10 most cashed up psychedelics companies right now

    “In business, cash is oxygen” – Gary Vaynerchuk Psychedelics is a cash-intensive business. Earlier in the week, I wrote about how clinical trials alone cost companies tens, sometimes hundreds of millions of dollars. And that’s only part of the picture. According to Tufts Center for the Study of Drug Development, bringing a new FDA-approved drug…

  • Bright Minds Biosciences (DRUG.C) is actually really tight

    Bright Minds Biosciences (DRUG.C) is actually really tight

    Serotonin over psychedelics Bright Minds Biosciences (DRUG.C) isn’t banking on recreational psychedelics being relevant any time soon, they aren’t selling mushroom powder, and don’t own any ketamine clinics. Rather, they are developing novel therapeutics to improve the lives of people with severe and life-altering diseases with a focus on 5-HT (serotonin) medicines. The company does…

  • Atai and Psybio: A closer look at two very different upcoming psychedelics IPO’s for 2021

    Atai and Psybio: A closer look at two very different upcoming psychedelics IPO’s for 2021

    IPO’s come in all shapes and sizes, some are giants with billionaire support, and others don’t have a pitch deck readily available. Investors get giddy with news of IPO’s as it signals a chance to get in early. It’s important to note that ‘getting in early’ isn’t a guarantee in an IPO, relatively speaking. Take…